Search

Search Constraints

You searched for: Author/Creator Khan, Freeha

Search Results

3. Colonic Biopsy Pyroptosis Predicts Clinical Response to Vedolizumab in Crohn's Disease: 734. (October 2019)

7. Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease. Issue 10 (18th September 2020)

8. Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease. Issue 10 (25th September 2019)

9. P087 ILEAL BIOMARKER OF INNATE IMMUNE ACTIVATION CAN PREDICT CLINICAL RESPONSE TO VEDOLIZUMAB IN CROHN'S DISEASE. (7th February 2019)